Esther Siteur-van Rijnstra

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte et al. · JAMA Oncology · 2022 · 85 citations · Full text

Medicine, Immunology, Oncology +17

Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1

Mireille Centlivre, Nicolas Legrand, Sofieke Klamer et al. · Molecular Therapy — Nucleic Acids · 2013 · 51 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers

Rosan A van Zoest, Jonathan Underwood, Davide De Francesco et al. · The Journal of Infectious Diseases · 2017 · 49 citations · Full text

Veterinary Medicine, Infectious Diseases, Neuroscience +15

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

Yme U. van der Velden, Marloes Grobben, Tom G. Caniels et al. · Scientific Reports · 2022 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte et al. · EClinicalMedicine · 2023 · 17 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17